期刊文献+

奥沙利铂联合5-氟脲嘧啶和醛氢叶酸钙时辰化疗26例进展期胃癌的临床观察

The Clinical Oberservation Chronotherapy of Combined 5-Fluorouracil Oxaliplatin and Leucovor in for Advanced Gastric Cancer
下载PDF
导出
摘要 目的:观察奥沙利铂(L-OHP)联合5-氟脲嘧啶(5-Fu)、醛氢叶酸钙(FA)方案(FFL)时辰输注法治疗晚期胃癌的疗效和不良反应。方法:FFL方案时辰输注治疗26例晚期胃癌患者,L-OHP每天25mg/m2、5-Fu每天600 mg/m2、FA每天300 mg/m2,四通道程控时辰输液泵连续给药4 d,每14 d为1个周期,至少用2个周期。结果:26例晚期胃癌患者中,完全缓解(CR)2例(7.7%),部分缓解(PR)13例(50.0%),稳定(SD)6例(23.1%),进展(PD)5例(19.2%),总有效率为57.7%。在80个周期的化疗中,最常见的不良反应为血液学毒性、胃肠道毒性、外周神经毒性,但均以Ⅰ度为主,2例发生Ⅲ度中性粒细胞减少,血小板减少、呕吐和口腔黏膜炎分别发生1例次,未出现Ⅳ度不良反应。中位缓解时间为3.5个月,中位肿瘤进展时间为4.5个月,全组患者中位生存期为8个月。结论:FFL方案时辰输注法是治疗晚期胃癌安全有效的化疗方案。 Objective: To observation effect and side reaction chronotherapy of combined 5 - Fu,Oxaliplatin and Leucovorin for advanced gastric cancer. Method: We use multichannel programmable infusion pump for 26 cases advanced gastric cancer total 4 days. Which was repeated every 2 -- 3 weeks for at least 2 cycles. Reasult: Of 26 cases, 2 cases (7.7 % ) complete remission, 13 cases(50.0 % ) partial remission, 6 cases(23.1% ) stable disease, 5 cases( 19.2 % )progressive disease, total response rate 57.7 %. Total 80 cycles chemotherapy. Most common adverse reaction is hematology toxity, gastrointestinal toxity, peripheral nerve toxity, most of them 1 grade. 3 grade neutropeni, thrombocytopenic, vomiting, oral mucosa inflammation. No 4 grade adverse reaction. Median remission duration 3. 5 months, Median tumor progress duration 4, 5 months. Median survival duration 8 months. Conclusion: FFL chronotherapy is safty and effective methods for advanced gastric cancer.
作者 王洪武
出处 《内蒙古医学杂志》 2009年第4期422-423,共2页 Inner Mongolia Medical Journal
关键词 胃肿瘤 奥沙利铂 5-氟脲嘧啶 醛氢叶酸钙 时辰化疗 Gastric cancer Oxaliplatin 5 - Fluorouracil Leucovor Chronotherapy
  • 相关文献

参考文献3

二级参考文献22

  • 1De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
  • 2Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
  • 3Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
  • 4De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
  • 5De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
  • 6孙燕 周际昌.临床肿瘤内科手册:第二版[M].北京人民出版社,1996.18-26.
  • 7D. R. Penberthy,T. A. Rich,C. H. Shelton,R. Adams,J. S. Minasi,R. S. Jones.A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer[J].Annals of Oncology.2001(5)
  • 8Buchi K N,Moore J G,Hrushesky W J,et al.Circadian rhythm of cellular proliferation in the human rectal mucosa[].Gastroenterology.1991
  • 9Smaaland R,Lote K,Sothern RB,et al.DNA synthesis and ploidy in non-Hodgkin’s lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling[].Cancer Research.1993
  • 10Filipski E,Amat S,Lemaigre G,et al.Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice[].Journal of Pharmacology and Experimental Therapeutics.1999

共引文献422

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部